Get the Stockscreener App
78.50
0.00%
0.00
Livanova Plc stock is traded at $78.50, with a volume of 1.43M.
It is up +0.00% in the last 24 hours and up +8.68% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$78.50
Open:
$79.66
24h Volume:
1.43M
Relative Volume:
1.80
Market Cap:
$4.31B
Revenue:
$1.43B
Net Income/Loss:
$107.13M
P/E Ratio:
40.52
EPS:
1.9372
Net Cash Flow:
$161.04M
1W Performance:
-1.80%
1M Performance:
+8.68%
6M Performance:
+26.45%
1Y Performance:
+73.79%
1-Day Range:
$77.71
$80.45
1-Week Range:
$77.71
$80.95
52-Week Range:
$41.02
$80.95
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.50 | 4.31B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LivaNova PLC (LIVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
LivaNova PLC (LIVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LivaNova PLC (LIVN) Institutional Confidence - TradingKey
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
LivaNova (LIVN) director logs RSU vesting, tax withholding and new 2027 RSU grant - Stock Titan
[Form 4] LivaNova PLC Insider Trading Activity - Stock Titan
LivaNova PLC (LIVN) director trades shares, receives 2,383 new RSUs - Stock Titan
LivaNova (LIVN) director logs RSU vesting, tax withholding and new grant - Stock Titan
LivaNova (LIVN) director reports RSU vesting, tax withholding and new grant - Stock Titan
LivaNova (LIVN) officer vests RSUs as 1,032 shares withheld for tax - Stock Titan
LivaNova (LIVN) director Jette Nygaard-Andersen receives 2,383 RSU grant - Stock Titan
LivaNova (LIVN) director settles RSUs, withholds shares for taxes and receives new RSU grant - Stock Titan
LivaNova (LIVN) director logs RSU vesting, tax withholding and 2027 grant - Stock Titan
LivaNova (LIVN) director Story Brooke reports RSU vesting, tax withholding and new grant - Stock Titan
LivaNova (LIVN) director logs RSU vesting, tax withholding and new 2027 grant - Stock Titan
LivaNova Reports Improved OSA Outcomes With PolySync Programming - Yahoo Finance
LivaNova demonstrates 84.5% cumulative response rate with PolySync programming in OSPREY study for obstructive sleep apnea - MSN
LivaNova’s programming algorithm boosts response rates in sleep apnoea patients - Medical Device Network
LivaNova (LIVN) Reports Promising Outcomes for Sleep Apnea Treat - GuruFocus
LivaNova sleep apnea therapy shows 84.5% response rate with new algorithm - Investing.com
LIVANOVA reports 84.5% response rate with PolySync in sleep apnea study - StreetInsider
(LIVN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LivaNova PLC (NASDAQ: LIVN) insider sells 1,800 shares for $136,350 - Stock Titan
LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea - Business Wire
Is LivaNova’s (LIVN) Boardroom Refresh Quietly Reframing Its Long-Term Risk and Strategy Playbook? - simplywall.st
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
Jette Nygaard-Andersen named director of LivaNova board - Medical Buyer
LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder Returns - Yahoo Finance
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova adds Jette Nygaard-Andersen to board of directors - Investing.com UK
LivaNova adds Jette Nygaard-Andersen to board of directors By Investing.com - Investing.com Australia
Jette Nygaard-Andersen Joins LivaNova Board as a New Director - The Joplin Globe
LivaNova PLC Announces Board and Committee Changes - marketscreener.com
LivaNova (NASDAQ: LIVN) director Jette Nygaard-Andersen reports zero common stock on Form 3 - Stock Titan
LivaNova (NASDAQ: LIVN) AGM backs directors, pay and buyback powers - Stock Titan
LivaNova Stock: My Targets Hold, Maintaining My Rating For 2H26 (NASDAQ:LIVN) - Seeking Alpha
LivaNova stock hits 52-week high at 76.92 USD - Investing.com
LivaNova stock hits 52-week high at 76.92 USD By Investing.com - Investing.com Nigeria
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
LivaNova PLC (LIVN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
LIVN: Improved VNS reimbursement and manufacturing scale drive growth, with OSA and new launches ahead - TradingView
LivaNova appoints Anne Liddy as chief legal officer - MSN
LivaNova beats estimates but shares fall 2% on guidance concerns - Investing.com
Earnings call transcript: LivaNova PLC beats Q1 2026 estimates, shares rise - Investing.com
LivaNova names Anne Liddy as chief legal officer By Investing.com - Investing.com Australia
LivaNova names Anne Liddy as chief legal officer - Investing.com
LivaNova Appoints Anne Liddy as Chief Legal Officer - The Joplin Globe
LivaNova Q1 2026 slides: double-digit growth drives guidance raise - Investing.com
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):